See the DrugPatentWatch profile for vascepa

Vascepa (icosapent ethyl) is a prescription medication approved for use in the United States to reduce the risk of cardiovascular events, such as heart attacks and strokes, in certain patients [1]. Common adverse effects associated with Vascepa include:

1. Infections: Upper respiratory tract infections, including the common cold, have been reported frequently in patients taking Vascepa [2].
2. Gastrointestinal issues: Diarrhea, nausea, and abdominal pain are common gastrointestinal side effects experienced by patients taking Vascepa [2].
3. Musculoskeletal pain: Myalgia (muscle pain) and arthralgia (joint pain) have been reported in patients taking Vascepa [2].
4. Flu-like symptoms: Some patients have reported experiencing flu-like symptoms, such as fatigue, headache, and fever, while taking Vascepa [2].
5. Elevated liver enzymes: Increases in liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), have been observed in patients taking Vascepa [2].
6. Increased bleeding risk: Vascepa may increase the risk of bleeding, particularly in patients taking anticoagulant or antiplatelet medications [2].

It is essential to consult with a healthcare provider for a comprehensive list of potential adverse effects and to discuss any concerns or questions about taking Vascepa [2].

Sources:
[1] "Icosapent Ethyl Capsules, for Oral Use." DailyMed, U.S. National Library of Medicine, <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5d316f7e-d58e-4e1f-a2d2-a9e2f96a2f9e&type=display>.
[2] "Icosapent Ethyl (Vascepa): Drug Uses, Dosage, Side Effects, Interactions, and Warnings." RxList, <https://www.rxlist.com/icosapent-ethyl-vascepa-drug.htm>.
[3] "Icosapent Ethyl (Vascepa)." DrugPatentWatch, <https://www.drugpatentwatch.com/drugs/icosapent-ethyl>.